AAV-ADDL mab (BGF67) WT Cas9-ASGR1 for B Cell Engineering (CAT#: BGS-0524-CR641)

The product is a highly efficient, inducible WT Cas9-ASGR1 gene-editing based novel AAV packaging system that can be used to mediate researches involving anti-ADDL mab (BGF67) in Human B cell engineering.

Datasheet

Specifications

Clone BGF67
Host Mouse
Packaging Cell Line HEK 293
Vector Promoter CMV
Rep Rep78
Capsid P24
Envelope VSV-G
Matrix N-terminal
Size ~20kb
Genome dsRNA
Virus Type AAV
Cofactor Requirement No Mg²⁺
Particles/mL 9.5 × 10¹¹
PFU/mL 7.9 × 10¹¹
TU/mL 6.6 × 10¹¹
Cas9 WT Cas9
sgRNA ASGR1
Engineered B Cell Human B cells

Target Information

Target ADDL
Alternative Names ADDL; Amyloid beta-derived diffusible ligands
Gene ID 120(Human)
UniProt ID Q9UEY8(Human)

Product Properties

Format Liquid
Shipping The product is shipped by dry ice.
Storage Upon receipt, store immediately at -80°C or lower for long-term storage. Avoid freeze/thaw cycles.
COA

Certificate of Analysis Lookup

To download a Certificate of Analysis, please enter a lot number in the search box below. Note: Certificate of Analysis not available for kit components.

Lot Number
! For Research Use Only | Not For Clinical Use

Related products